Remove 2025 Remove Communication Remove Pharmaceutical Companies
article thumbnail

The Power of Healthcare Branding: Strategies for Pharma Marketing Success in 2025

Pharma Marketing Network

In an increasingly competitive pharmaceutical landscape, the significance of healthcare branding has never been more pronounced. As we approach 2025, the ability of pharmaceutical companies to effectively craft and communicate their brand identity will play a pivotal role in determining their market success.

article thumbnail

op Pharma Marketing Trends Shaping the Future of Healthcare in 2025

Pharma Marketing Network

As we approach 2025, the pharmaceutical industry is witnessing a seismic shift in marketing strategies, driven by technological advancements and evolving consumer expectations. With the increasing digitization of healthcare, pharmaceutical companies are leveraging digital platforms to reach broader audiences more effectively.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Influence of 5G on Healthcare

Viseven

Although 5G is currently limited to large cities in developed countries, by around 2025, we can expect its reach will extend beyond the urban areas. As this trend unfolds, it is vital to understand the benefits 5G brings, how it impacts healthcare communication , and how healthcare businesses can leverage it. What Is 5G?

article thumbnail

Getting Creative with Sustainability | How Pharma Engages

Pharma Marketing Network

The wave of interest in sustainability follows the value chain from top-tier pharmaceutical companies to their suppliers of every size. About 80% of pharmaceutical companies have announced a commitment to becoming carbon-neutral or made a net-zero pledge for carbon emissions. Health for Humanity 2025 Goals.

article thumbnail

Osteoporosis treatment options – down to the bare bones

pharmaphorum

However, patent protection remains in some major markets, including France, Italy, Spain, and the UK until 2025. The question is whether other major pharmaceutical companies will be attracted to the space – particularly when areas such as oncology and orphan drugs currently provide a larger return on investment.

article thumbnail

Connected customer data: a golden opportunity for pharma marketers

pharmaphorum

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. It flows from every direction in torrents to create huge opportunities to address the world’s mounting health issues.

article thumbnail

Why demand is rising for secure and climate-controlled gene therapy services

Pharmaceutical Technology

Pharmaceutical companies are putting their trust in the immense potential this new generation of medicine has for treating individuals with rare genetic diseases, which currently affect an estimated 280 million patients worldwide.